TherapeuticsMD, Inc. Other Comprehensive Income (Loss), Net of Tax
TherapeuticsMD, Inc. (TXMD) reported Other Comprehensive Income (Loss), Net of Tax of $0 for the 3-month period ending 2023-09-30, per its 10-Q filed 2023-11-14.
Discontinued › Income Statement › Unrealized Gains
us-gaap:OtherComprehensiveIncomeLossNetOfTax · last filed 2023-11-14
- TherapeuticsMD, Inc. other comprehensive income (loss), net of tax for the quarter ending 2023-09-30 was $0.00.
- TherapeuticsMD, Inc. other comprehensive income (loss), net of tax for the quarter ending 2022-09-30 was $0.00.
| Period end | Other Comprehensive Income (Loss), Net of Tax 3 month | Other Comprehensive Income (Loss), Net of Tax 9 month |
|---|---|---|
| 2023-09-30 | $0.00 10-Q · filed 2023-11-14 | $0.00 10-Q · filed 2023-11-14 |
| 2022-09-30 | $0.00 10-Q · filed 2023-11-14 | $0.00 10-Q · filed 2023-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |